# A Study of Intra-Ophthalmic Artery Topotecan Infusion for the Treatment of Retinoblastoma

> **NCT01466855** · EARLY_PHASE1 · TERMINATED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 36 (actual)

## Conditions studied

- Retinoblastoma

## Interventions

- **DRUG:** Intra-Ophthalmic Artery Topotecan Infusion

## Key facts

- **NCT ID:** NCT01466855
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-10
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 36 (ACTUAL)
- **Why stopped:** Competing studies
- **Last updated:** 2020-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01466855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01466855, "A Study of Intra-Ophthalmic Artery Topotecan Infusion for the Treatment of Retinoblastoma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01466855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*